• News & Press
  • Events
  • Careers
My Maxim Account
Skip to content
  • The Firm
      • Overview
      • Corporate Facts
      • Executive Management Team
      • Social Responsibility
      • Clearing Firm / SIPC
      • Locations
  • Investment Banking
      • Overview
      • Services
      • Recent Transactions
      • Investment Banking Team
  • Equity Research
      • Overview
        - Market Sector Snapshot
      • Research Team
      • Sample Reports
      • Maxim Research Universe
  • Capital Markets
      • Overview
      • Equity Capital Markets
        • Institutional Sales & Trading
        • Syndicate
        • International Equities
        • Options & Derivatives
      • Research
      • Fixed Income Group
        • High Grade and High Yield Corporate Bonds
        • Residential Mortgage Backed Securities & Specified Pools
        • Preferred Stock and Hybrid Capital
        • Emerging Markets
        • Convertible Bonds
        • Municipal Bonds
        • Structured Products
        • U.S. Treasury
        • Certificate of Deposit
      • Prime Brokerage
        • Reporting
        • Start-up & Capital Solutions
      • Corporate Access
      • Capital Markets Team
  • Wealth Management
      • Overview
      • Private Client Services
      • Business Services
      • Estate Planning/Insurance
      • Advisory Services
      • Executive & Corporate Services
      • Wealth Management Team
  • Merchant Capital
      • Overview
      • Completed Transactions
      • Recent Developments
      • Merchant Capital Team
← ContraFect Chairman and CEO Steven C. Gilman Takes Temporary Medical Leave
Nephros Inc_PIPE_1_2_Million_March 2017 →

Diffusion Pharmaceuticals Inc_Private Placement_25_0_Million_March 2017

This entry was posted in Sector: Healthcare, Sector: Other. Bookmark the permalink.
← ContraFect Chairman and CEO Steven C. Gilman Takes Temporary Medical Leave
Nephros Inc_PIPE_1_2_Million_March 2017 →
  • right-ER-team-vendetti
  • right-ER-team-kolbert
  • right-ER-team-kinstlinger
  • Legal

    • Web Privacy
    • Client Privacy
    • Public Disclosures
    • Terms and Conditions
    • Business Continuity Plan
    • Third Party Research
  • Quick Links

    • The Firm
    • FINRA Broker Check
    • News & Press
    • Careers
    • Contact Us

© Maxim Group, LLC.

(800) 724-0761

Member: FINRA, NASDAQ, NYSE Arca, IEX, SIPC